Key facts
- This page summarizes Christopher Downs's Form 4 filing for CNS Pharmaceuticals, Inc. (CNSP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 07 Dec 2021, 07:30.
Christopher Downs - 06 Dec 2021 Form 4 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)
- Signature
- /s/ Christopher Downs
- Issuer symbol
- CNSP
- Transactions as of
- 06 Dec 2021
- Net transactions value
- +$4,702
- Form type
- 4
- Filing time
- 07 Dec 2021, 07:30:08 UTC
- Previous filing
- 22 Nov 2021
- Next filing
- 11 Feb 2022
- SEC
- View on sec.gov
Key filing fact
Christopher Downs filed Form 4 for CNS Pharmaceuticals, Inc. (CNSP) on 07 Dec 2021.
Change
- Previous filing in this sequence was filed on 22 Nov 2021.
- Current net transaction value: +$4,702.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
CNSP
transaction
Common Stock
Purchase
- Transaction value
- $4,702
- Shares
- +5,000
- Change %
- +3.4%
- Price
- $0.9403
- Shares after
- 151,500
- Date
- 06 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $0.9400 to $0.947299. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |